TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited announced a change in the director’s interest notice, specifically regarding Matthew Muscio’s acquisition of 3,800 ordinary shares through an on-market purchase. This change reflects an increase in Muscio’s holdings, indicating a potential vote of confidence in the company’s future prospects.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services focused on healthcare distribution and logistics.
Average Trading Volume: 140,909
Technical Sentiment Signal: Sell
Current Market Cap: A$5.07B
See more data about EBO stock on TipRanks’ Stock Analysis page.